|
|









Research done on APS Therapy |
Copyright © 2010 APS Therapy All Rights Reserved. |
Different clinical studies in New Zealand, Canada and South Africa show the significant positive effect of APS Therapy on the sensation of pain and the mobility of the treated persons. Research studies were done 751 patients with disorders like osteoarthritis of the knee, osteoporoses of the lower vertebra, neurosurgical pain, and chronic pain, different muscle soreness's and slow healing wounds. Research proves that 73% of the patients with osteoporoses experience a positive effect directly after the first treatment. After the second treatment is number has increased to even 83%. The group of patients that experience no effect more than two treatments is only 13%. This shows that APS Therapy has a positive effect on the patient in an early stage of the treatment. Some interesting researches can be downloaded from the APS Therapy Worldwide site. Click here to see the research. (www.apstherapy.com) |
THE SOUTH AFRICAN MEDICAL RESEARCH COUNCIL (MRC) AND THE UNIVERSITY OF CAPE TOWN Head of Project Prof. A.E. Bunn (Medical Research Council) Prof. L. Meyers (Head of the Rheumatic Disease Unit: Faculty of Medicine University of Cape Town). Study 40 Patients with painful patient's osteoarthritis of the knees were recruited from a list of patients requiring total knee replacements. Method Double-blinded placebo-controlled study measuring self-reported pain, morning stiffness and night pain. Results APS Therapy reduces pain, morning stiffness and night pain to a highly significant degree (p=0,0003). Conclusion Prof. A.E. Bunn: "The fact that the sample group was chosen from severe osteoarthritic patients requiring total knee replacements makes this result very were impressive". Prof.L. Meyers: "This study has shown that the use of pain relief pulse (APS) shows that after two (2) sequential applications significant reduction of self reported pain is achieved". THE UNIVERSITY OF DURBAN WESTVILLE Head of Project Mr. C.A. Liggings (Senior lecturer and Head of the Department of Physiotherapy; University of Durban Westville and King Edward Hospital.) Study 10 Patients with a variety of pain conditions and who had showed minimal or no response to other electrotherapeutic modalities were selected Method Patients were treated with APS Therapy after the treatment with other modalities. Visual Analogue Pain Scale (VAPS) was used as criteria in this study. Results 40% of the patients required only one treatment to relieve pain completely (Numerical Pain Rating scale = 0-10); 80% of Patients had minimal pain by the end of two treatment sessions. (N.P.R.S = 0-2) Conclusion Mr. C.A. Liggins: "In the case of deep seated pain, the APS Therapy device was more effective than other modalities". THE UNIVERSITY OF PRETORIA Head of Project Dr. J. du Preez (Senior Consultant, Department of Neurosurgery; University of Pretoria and Consultant; Gauteng Provincial Administration). Study 31 Patients suffering neurosurgical pain conditions and awaiting destructive surgery were selected. Method Clinical experience over a period of three months. Results A significant improvement in certain surgical conditions. Conclusion Dr. J. du Preez: "For the past few years APS Therapy has been used with success as an adjunctive to neurosurgery in different patients, presenting with both acute but mostly chronic pain states. We propose that all patients waiting for destructive surgery should first be put on a thorough trial of APS Therapy". THE UNIVERSITY OF PRETORIA Head of Project JC Seegers, M-L Lottering, AM Joubert, F Joubert, AM Koorts, CA Engelbrecht and DH van Papendorp (Departments of Physiology, Biochemistry and Physics, University of Pretoria, South Africa) Study The aim of the study was to investigate the effects of the application of a small amplitude, direct current (DC), pulsed electrical fuel on extracellular and intra-cellular ATP levels and total (intracellular and secreted) cAMP levels in vitro and in vivo systems. Method Two APS devices were used, delivering a periodic, direct current, pulsed electrical field. The pulsed frequency used was 150Hz and the duration of treatment was 8 minutes for all studies. ATP was determined with an ATP Bioluminescence assay kit. cAMP was determined with a cAMP Enzyme immuno-assay encephalin system. Results Results of ATP levels in vitro showed that the total concentrations of ATP (intracellular and extracellular) was however significantly higher in the electrically treated cells. The total cAMP levels were decreased in cultured HeLa cells with electrical treatment. Further results showed the total cAMP levels were, significantly increased in isolated lymphocytes with electrical treatment. Interestingly, an opposite effect was seen in the plasma samples (ATP levels in vivo). In all 9 of the volunteers a statistically decrease were seen with electrical treatment. In all 9 plasma samples, cAMP levels in vivo were decreased after electrical treatment. Conclusion The clear effects on ATP and cAMP levels seen in these experiments indicate that the frequency, waveform and signal strength of the applied electrical field, is suitable for effecting measurable changes in the body. However the differences in the nature of these effects seen in the in vivo and in vitro samples indicate that the effects are of a complex nature. Published The Medicine Journal, January/February, 2000 |
THE UNIVERSITY OF THE FREE STATE Head of Project Prof. C.L. Odendaal (Head of the Pain Control Unit; Dept. of Anaesthesiology; Faculty of Medicine; University of the Free State). Study 76 Patients with lower back pain due to osteoporosis, were selected. Method Randomised, double-blinded, placebo controlled study. Visual Analogue Pain Scale (VAPS) was the method. Results APS Therapy relieves pain to a statistically highly significant degree (p =0,0001 0,0033) Conclusion Prof. C.L. Odendaal: "Clinically the effect of treatment was very successful. APS treatment may be an effective treatment for chronic backache in the osteoporotic patient. Published The South African Journal of Anaesthesiology and Analgesia, March, 1999. THE UNIVERSITY OF WITWATERSRAND, JOHANNESBURG Head of Project Ms. P. Berger Physio (Wits), L. Matzer Msc M(University of Pretoria) Study Placebo controlled study on 99 patients with osteo arthritis (OA) of the knee to investigate the effectiveness of APS. Method Randomised single blind study. Visual Analogue Pain Scale was used. Knee flexion by goniometer. Results It was statistically proved that APS Therapy is effective in a treatment of patients with osteoarthritis in the knee. Conclusion The increased improvement in flexion in the APS group is remarkable considering that the treatment has ceased, yet, ongoing changes were occurring. The increased flexibility of the patients in the APS group enables the patient to participate more easily in an exercise regimen…and assists in the improvement of the quality of life of the osteo-arthirits patient" Ms. P. Berger. Published The South African Journal of Anaesthesiology and Analgesia, June, 1999. THE UNIVERSITY OF PRETORIA Head of Project Prof. D.H. van Papendorp (MBChB, PhD Med, Univ of Stellenbosch) Study Assessment of Pain Relief on 285 patients with chronic pain. Method Visual Analogue Pain Scale (VAPS) Mobility Index. Results The mean VAPS and MI improved significantly in the patient group as a whole. Conclusion Both on clinical grounds and by patient self assessment, APS Therapy appeared to be most beneficial. This study has also demonstrated significant clinical efficacy of the APS Device" Prof van Papendorp Published The Medicine Journal, January/February, 2000 THE UNIVERSITY OF PRETORIA Head of Project Prof. D.H. van Papendorp M.C Maritz and N Dippenaar (department of Physiology, University of Pretoria, South Africa) Study The aim of this pilot study was to investigate what effects APS Therapy has on 2 endogenous opioids viz endorphin, and leu-encelphalin, and on the nonopioid neuropeptide, Substance P. Results Beta endorphin concentrations showed a fourfold increase in the pain group while the control group showed a 60% increase. Plasma leucine encephaline concentrations increased with APS therapy in the pain group. APS treatment had no effect on absorbance readings of the control group. Interestingly though, the absorbance readings of the pain group increased slightly after APS therapy, approaching those of the control group. Conclusion The specific reason for the progressive increase in leucine encephalin concentrations with APS therapy in the pain group, is attributed to the presently unknown effect of electrical currents of specific quality and duration on the b sulting in artificially increased levels of substances resulting in attenuation of pain for pain relief. Combined with the increase in plasma endorphin concentrations demonstrated in this study, leucine encephalin may be internally involved in restructuring the relieve of chronic pain in humans. Published Medicine Journal, January/February, 2002; 44(1); 36-40 |
STUDIES CONDUCTED New Zealand Head of Project Dr. P. James Watt, Auckland, New Zealand Study 32 patients treated for a wide range of musculoskeletal pain conditions, using the VAPS. Results 78% reported a positive response to the first treatment. Of the 24 need patients that received a follow-up treatment, 83% reported a positive response. Conclusion "Generally the treatment was used in conjunction with mobilization of manipulation and was a useful addendum. The efficacy was generally similar to acupuncture used in the same situation but was easier to administer and on occasions had very successful relief of pain… "I found the device easy to use and particularly useful in reducing the initial discomfort mobilization. This resulted in a reduced need for pharmaceutical prescription" Dr. Watt Head of Project Dr. P. Botes, Auckland, New Zealand Study 38 patients treated for a wide range of musco-skeletal pain conditions and to determine the impact of the APS device on wound healing and mobility, using the VAPS Results After the first treatments, the average VAPS score fell 40%. After the second treatments, the average VAPS score fell 38%. Both changes in VAPS scores were significant, with p < 0.0001 for the corresponding t-tests. 3 Participants presented with slow-healing wounds, all of which reported accelerated rates of healing (in addition to reduced discomfort). Conclusion The efficiency was generally good, especially for conditions relating to the lumbar/sacroiliac region. In addition to pain relief, the device appeared to have a noticeable effect on mobility. Those who presented with slow-healing wounds experienced dramatically accelerated rates of healing. There was also a reduced need for pharmaceutical prescription" Dr. Botes. South Africa Head of Project Prof. C.J. Zeelie (Unit for Health Services, Port Elizabeth Technikon) Study In this project the ability of electro-medicine, and in particular a device known as APS Compact, to relieve pain of 243 patients was investigated. Individuals were treated for a variety of pains encountered in various body parts including both hard and soft tissue. Results In all cases good pain relief was observed. In some cases the extent of pain relief was not very great, but the relief experienced was so significantly profound that the individual who had not been able to sleep for several days actually fell asleep during the treatment. Conclusion The APS Compact was found to be extremely effective in the treatment of a wide variety of pains, in both soft and hard tissues of the body. In a wide spectrum of health or medical disorders the device was found to be useful in the treatment of pain in both young and old, sick and healthy individuals. Good accumulative and surprising residual effects were observed in the treatment of pain in terminally ill patients. The APS Compact is a good, inexpensive alternative for conventional medicine. Canada Head of Project Dr. C. Marais, Saskatchewan, Canada Study 174 patients treated for 55 different ailments over 3 months period. Results From the 157 patients treated (17 did not return for follow-up treatments), the following observations were made: • 72% improved or felt that APS therapy was better than other treatment modalities • 28% did not improve or felt that APS therapy was equal to other modalities • 50% had immediate relief of pain • 20% had immediate improvement of swelling. • 54% had immediate improvement of stiffness. • 50% had immediate improvement of mobility. • 23% had gradual improvement of pain. • 8% had a gradual improvement of swelling. • 15% had gradual improvement of stiffness. • 14% had gradual improvement of mobility. |
"...but the relief experienced was so significantly profound that the individual who had not been able to sleep for several days actually fell asleep during the treatment." Prof. C.J. Zeelie |